Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVipera Regulatory News (VIP)

Share Price Information for Vipera (VIP)

Share Price is delayed by 15 minutes
Get Live Data
201.50    7.50 (3.87%)
Bid:
194.00
Ask:
209.00
Spread: 15.00 (7.732%)
Market Cap: £82.54m
VIP Live PriceLast checked at - London Stock Exchange

Intraday Vipera Share Chart

Partnership with Equens

4 Jun 2013 07:00

RNS Number : 1918G
Vipera PLC
04 June 2013
 



 

 

For immediate release 4 June 2013

 

Vipera - Equens partnership

 

Vipera, the specialist provider of mobile financial services, today announces that Equens (www.equens.com ), the largest pan-European payment processor, and who leads the market for future-proof payments and card processing solutions, has recently started to offer Motif, the Vipera product, to its customers. This follows an in depth evaluation conducted together with one of their German bank customers, who has now progressed to conducting a trial implementation of Motif. 

 

Commenting on partnership, Vipera Chief Executive Officer Marco Casartelli said:

"This new partnership reinforces Vipera's position as a growing provider of mobile financial services. The strategic endorsement by a European brand leader in payment processing comes at an exciting time. Like Vipera, Equens is working with leading players to ensure that future mobile payment technologies are as easy, simple and secure as card-based transactions are today."

 

"Providing a trusted platform to allow banking and payments via mobile is key to Vipera aspirations and we are delighted by the role we are playing in making that happen. Financial institutions demand resilient and robust infrastructure and Vipera's credentials in this arena are now starting to give it increased traction in many business segments."

 

 -Ends-

 Vipera PLC

Marco Casartelli

Tel: +39 02 863 371

Martin Perrin

Tel: +44 (0) 7785 505 337

Beaumont Cornish Limited (Nomad)

Tel: +44 (0) 20 7628 3396

Roland Cornish

Felicity Geidt

 

 

Notes to Editors

 

Equens SE is one of the largest payment processors in Europe, leading the market for future-proof payment and card solutions. With clients and partnerships in multiple European countries, the company offers pan-European market coverage from offices in four countries - the Netherlands, Germany, Italy and Finland. And with an annual processing volume of 9.7 billion payments and 3.9 billion POS and ATM transactions, Equens SE has a European market share of more than 12.5%.

 

Vipera provides software and services to banks and financial institutions, primarily through its Motif platform, to enable mobile access to personal financial services. Additionally Vipera's software enables Government and corporate entities to allow their services and consumer transactions to take place on mobile platforms. All products within the Motif suite share market leading security models, a consumer friendly interface and support for different devices and languages.

 

Vipera's partnership with Equens, provides an extensive set of mobile financial services, from cross-bank mobile banking to money transfer and real time financial transaction alerting. Vipera has also integrated additional functionalities such as airtime top-up, QR-code and NFC payment, couponing and loyalty schemes.

 

Vipera's headquarters are in Milan and it listed on the London Stock Exchange (AIM: VIP.L). For further information, please visit www.vipera.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSUFWDFDSESM
Date   Source Headline
15th Dec 20234:30 pmRNSDirector/PDMR Shareholding
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20239:06 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
21st Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20237:00 amRNSHalf-year Report
15th Nov 20237:00 amRNSChange of Auditor
27th Oct 20237:00 amRNSPortfolio Update
17th Oct 20237:00 amRNSAppointment of Corporate Broker
15th Sep 202310:46 amRNSHolding(s) in Company
13th Sep 20233:15 pmRNSTransaction in Own Shares
11th Sep 20234:57 pmRNSTransaction in Own Shares
8th Sep 202310:49 amRNSDividend Declaration
2nd Aug 20232:02 pmRNSResult of AGM
17th Jul 20234:58 pmRNSTransaction in Own Shares
7th Jul 20237:00 amRNSTransaction in Own Shares
26th Jun 20236:28 pmRNSAnnual Financial Report
14th Apr 20237:00 amRNSAcquisition and Year End Portfolio Valuation
1st Mar 20237:00 amRNSTransaction in Own Shares
22nd Feb 202310:09 amRNSTransaction in Own Shares
17th Feb 20237:00 amRNSTransaction in Own Shares
8th Feb 20233:13 pmRNSDividend Declaration
3rd Feb 20237:00 amRNSTrading Statement
18th Nov 202210:36 amRNSDividend Declaration
18th Nov 202210:19 amRNSHalf-year Report
7th Nov 20227:00 amRNSMonth End Net Asset Values
25th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20227:00 amRNSTransaction in Own Shares
6th Oct 20224:05 pmRNSMonth End Net Asset Values - Replacement
5th Oct 20224:54 pmRNSStatement re MAR
5th Oct 20224:50 pmRNSMonth End Net Asset Values
22nd Sep 20227:00 amRNSDividend Declaration
6th Sep 20223:38 pmRNSMonth End Net Asset Values
1st Sep 20227:00 amRNSTransaction in Own Shares
31st Aug 20227:00 amRNSTransaction in Own Shares
18th Aug 20227:00 amRNSTransaction in Own Shares
5th Aug 20223:37 pmRNSMonth End Net Asset Values
3rd Aug 20227:00 amRNSTransaction in Own Shares
26th Jul 20222:01 pmRNSDirectorate Change
19th Jul 20227:00 amRNSTransaction in Own Shares
18th Jul 20227:00 amRNSTransaction in Own Shares
15th Jul 20227:00 amRNSTransaction in Own Shares
14th Jul 20227:00 amRNSTransaction in Own Shares
13th Jul 20227:00 amRNSTransaction in Own Shares
12th Jul 20229:47 amRNSTransaction in Own Shares
8th Jul 20221:22 pmRNSResult of AGM
7th Jul 20229:37 amRNSMonth End Net Asset Values

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.